by Natasha Davie | Oct 17, 2012
It has taken just six years since the release of his seminal publication on the genetic reprogramming of human somatic cells for Shinya Yamanaka to be awarded the most prestigious of all accolades: the Nobel Prize. Compare that to his co-recipient, Sir John B. Gurdon,...
by Paul Krzyzanowski | Sep 20, 2012
[pullquote]How will Romney’s opinion change in light of papers, which describe healthy mice being created from iPS cells?[/pullquote]As 2012 slowly creeps on we can finally see November’s Presidential Election in the United States on the horizon marking the end of a...
by Lisa Willemse | Sep 6, 2012
It seems to me that the number of media stories on stem cell clinical trials (not just preclinical work) is on the increase. Take, for example, news last month of a new clinical trial to test cord blood stem cells as a treatment for autism. This particular...
by Lisa Willemse | Jun 1, 2012
Who was it that said “there are no original ideas”? The same person, perhaps, that said “great minds think alike”? Last week, we initiated a stem cell definition challenge via Twitter, asking followers to send their answers in 140 characters or...
by David Kent | May 24, 2012
As a basic researcher in stem cell biology, one of my biggest fears is moving too quickly with cell therapies that involve primitive, still largely mysterious, cell populations. At the World Stem Cells & Regenerative Medicine Congress meeting this week, I felt...
Comments